1. Home
  2. ABVC vs FEDU Comparison

ABVC vs FEDU Comparison

Compare ABVC & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVC
    SELLHOLDBUYas of 6 hours ago
  • FEDU
    SELLHOLDBUYas of 6 hours ago
  • Stock Information
  • Founded
  • ABVC 2015
  • FEDU 2007
  • Country
  • ABVC United States
  • FEDU China
  • Employees
  • ABVC N/A
  • FEDU N/A
  • Industry
  • ABVC Biotechnology: Pharmaceutical Preparations
  • FEDU
  • Sector
  • ABVC Health Care
  • FEDU
  • Exchange
  • ABVC Nasdaq
  • FEDU NYSE
  • Market Cap
  • ABVC 16.7M
  • FEDU 20.0M
  • IPO Year
  • ABVC N/A
  • FEDU 2017
  • Fundamental
  • Price
  • ABVC $0.75
  • FEDU $8.81
  • Analyst Decision
  • ABVC
  • FEDU
  • Analyst Count
  • ABVC 0
  • FEDU 0
  • Target Price
  • ABVC N/A
  • FEDU N/A
  • AVG Volume (30 Days)
  • ABVC 290.8K
  • FEDU 5.0K
  • Earning Date
  • ABVC 05-16-2025
  • FEDU 12-20-2024
  • Dividend Yield
  • ABVC N/A
  • FEDU 26.79%
  • EPS Growth
  • ABVC N/A
  • FEDU N/A
  • EPS
  • ABVC N/A
  • FEDU 0.12
  • Revenue
  • ABVC $509,788.00
  • FEDU $27,971,139.00
  • Revenue This Year
  • ABVC N/A
  • FEDU N/A
  • Revenue Next Year
  • ABVC N/A
  • FEDU N/A
  • P/E Ratio
  • ABVC N/A
  • FEDU $77.44
  • Revenue Growth
  • ABVC N/A
  • FEDU 141.14
  • 52 Week Low
  • ABVC $0.40
  • FEDU $7.41
  • 52 Week High
  • ABVC $1.73
  • FEDU $22.70
  • Technical
  • Relative Strength Index (RSI)
  • ABVC 51.27
  • FEDU 44.29
  • Support Level
  • ABVC $0.65
  • FEDU $8.81
  • Resistance Level
  • ABVC $1.40
  • FEDU $10.18
  • Average True Range (ATR)
  • ABVC 0.11
  • FEDU 0.63
  • MACD
  • ABVC 0.02
  • FEDU 0.04
  • Stochastic Oscillator
  • ABVC 21.86
  • FEDU 24.35

Stock Price Comparison Chart: ABVC vs FEDU

ABVC
FEDU
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April05101520253035404550556065ABVC VS FEDU

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use